Laura Rebekah Findley, PHARMD | |
7700 Hargrove Rd E, Cottondale, AL 35453-3810 | |
(205) 242-6286 | |
Not Available |
Full Name | Laura Rebekah Findley |
---|---|
Gender | Female |
Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
Location | 7700 Hargrove Rd E, Cottondale, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336596758 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 18715 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Laura Rebekah Findley, PHARMD 7700 Hargrove Rd E, Cottondale, AL 35453-3810 Ph: (205) 242-6286 | Laura Rebekah Findley, PHARMD 7700 Hargrove Rd E, Cottondale, AL 35453-3810 Ph: (205) 242-6286 |
News Archive
Mich. Gov. Rick Snyder pointed out - as part of his re-election bid - that 63,000 more low-income adults have signed up for the program than was projected this year.
TARIS Biomedical, a specialty pharmaceutical company pioneering the field of drug-device convergence for targeted therapies, announced today the successful completion of a Phase 1 clinical study of its intravesical drug-device convergence system designed to provide sustained-release of drug directly to the bladder.
New antibiotics for methicillin-resistant Staphylococcus aureus (MRSA) and other pesky bacteria. Andrei Osterman and collaborators have used comparisons of bacterial genomes to identify new targets for antibiotics and produced first-generation chemical inhibitors of a class of bacterial enzymes, called NadDs (nicotinate mononucleotide adenylyltransferases).
Dr. Florian Weinberg, from Prof. Dr. Tilman Brummer's research group at the Institute of Molecular Medicine and Cell Research of the University of Freiburg, joined forces with scientists from the Departments of Clinical Pathology and Medicine I of the University Medical Centre Freiburg and the Kinghorn Cancer Centre/Garvan Insitute in Australia in an international team that has identified a new target for cancer therapy.
› Verified 4 days ago